EIF2AK3 and Alzheimer disease: In addition, levels of p-PERK and downstream p-eIF2 were found to be elevated in the cortex and hippocampus of postmortem AD brain, suggesting the association of the PERK-eIF2α pathway in AD pathogenesis [26–28].